Provided by Tiger Trade Technology Pte. Ltd.

Xtant Medical

0.3380
-0.0421-11.08%
Pre-market: 0.3378-0.0002-0.06%07:01 EDT
Volume:455.60K
Turnover:161.70K
Market Cap:47.32M
PE:-4.25
High:0.3905
Open:0.3905
Low:0.3369
Close:0.3801
52wk High:0.9500
52wk Low:0.2702
Shares:140.00M
Float Shares:54.29M
Volume Ratio:0.20
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0795
EPS(LYR):0.0300
ROE:-25.16%
ROA:-3.75%
PB:1.18
PE(LYR):11.27

Loading ...

Adagio Medical Treats First Patient with Next-Generation vCLAS Ultra ULTA System Under FDA Expanded Access

Reuters
·
Aug 03

Retrieve Medical Partners with Clear to Integrate Clear1 Identity Verification into Medical Passport

Reuters
·
Jul 16

Xtant Medical Publishes 2025 Annual Report

Reuters
·
Jul 01

Retrieve Medical Signs Distribution Agreement with Sole Horizon for Retrieve Passport Platform

Reuters
·
Jun 30

Xtant Medical announces annual shareholder meeting

Reuters
·
Jun 23

Adagio Medical holds annual stockholder meeting

Reuters
·
Jun 17

Adagio Medical gets Nasdaq notice after shares trade below $1 bid-price minimum

Reuters
·
Jun 13

Adagio Medical submits FDA PMA application for vCLAS ventricular ablation system

Reuters
·
May 21

Xtant Medical Balances New Growth Bets With Near-Term Pain

TIPRANKS
·
May 20

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 15

Maxim Group Sticks to Their Buy Rating for Xtant Medical Holdings (XTNT)

TIPRANKS
·
May 14

Adagio Medical releases investor presentation on vCLAS ventricular tachycardia ablation system

Reuters
·
May 14

Xtant Medical Holdings Price Target Maintained With a $1.00/Share by BTIG

Dow Jones
·
May 14

Xtant Medical Q1 revenue falls less than expected, outlook raised

Reuters
·
May 13

Xtant Medical Hldgs Q1 EPS $(0.02), Inline, Sales $20.884M Beat $20.164M Estimate

Benzinga Earnings
·
May 13

Xtant Medical Outlook FY Revenue USD 101-105 Million

THOMSON REUTERS
·
May 13

Xtant Medical Q1 Revenue USD 20.9 Million

THOMSON REUTERS
·
May 13

Adagio Medical Q1 FY26 net loss narrows to $7 million; R&D expense falls to $2.7 million

Reuters
·
May 12

Xtant Medical to report Q1 results, host conference call May 13

Reuters
·
May 07

3 Promising Penny Stocks With Market Caps Under $200M

Simply Wall St.
·
May 01